• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基因表达序列分析确定的人类乳腺癌进展中的转录组变化。

Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.

作者信息

Abba Martin C, Drake Jeffrey A, Hawkins Kathleen A, Hu Yuhui, Sun Hongxia, Notcovich Cintia, Gaddis Sally, Sahin Aysegul, Baggerly Keith, Aldaz C Marcelo

机构信息

Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park - Research Division, Smithville, Texas, USA.

出版信息

Breast Cancer Res. 2004;6(5):R499-513. doi: 10.1186/bcr899. Epub 2004 Jul 6.

DOI:10.1186/bcr899
PMID:15318932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC549167/
Abstract

INTRODUCTION

Genomic and transcriptomic alterations affecting key cellular processes such us cell proliferation, differentiation and genomic stability are considered crucial for the development and progression of cancer. Most invasive breast carcinomas are known to derive from precursor in situ lesions. It is proposed that major global expression abnormalities occur in the transition from normal to premalignant stages and further progression to invasive stages. Serial analysis of gene expression (SAGE) was employed to generate a comprehensive global gene expression profile of the major changes occurring during breast cancer malignant evolution.

METHODS

In the present study we combined various normal and tumor SAGE libraries available in the public domain with sets of breast cancer SAGE libraries recently generated and sequenced in our laboratory. A recently developed modified t test was used to detect the genes differentially expressed.

RESULTS

We accumulated a total of approximately 1.7 million breast tissue-specific SAGE tags and monitored the behavior of more than 25,157 genes during early breast carcinogenesis. We detected 52 transcripts commonly deregulated across the board when comparing normal tissue with ductal carcinoma in situ, and 149 transcripts when comparing ductal carcinoma in situ with invasive ductal carcinoma (P < 0.01).

CONCLUSION

A major novelty of our study was the use of a statistical method that correctly accounts for the intra-SAGE and inter-SAGE library sources of variation. The most useful result of applying this modified t statistics beta binomial test is the identification of genes and gene families commonly deregulated across samples within each specific stage in the transition from normal to preinvasive and invasive stages of breast cancer development. Most of the gene expression abnormalities detected at the in situ stage were related to specific genes in charge of regulating the proper homeostasis between cell death and cell proliferation. The comparison of in situ lesions with fully invasive lesions, a much more heterogeneous group, clearly identified as the most importantly deregulated group of transcripts those encoding for various families of proteins in charge of extracellular matrix remodeling, invasion and cell motility functions.

摘要

引言

影响细胞增殖、分化和基因组稳定性等关键细胞过程的基因组和转录组改变被认为对癌症的发生和发展至关重要。大多数浸润性乳腺癌已知起源于原位前体病变。有人提出,在从正常阶段到癌前阶段以及进一步发展到浸润阶段的转变过程中会发生主要的全局表达异常。采用基因表达系列分析(SAGE)来生成乳腺癌恶性演变过程中发生的主要变化的全面全局基因表达谱。

方法

在本研究中,我们将公共领域中可用的各种正常和肿瘤SAGE文库与我们实验室最近生成并测序的一组乳腺癌SAGE文库相结合。使用最近开发的改良t检验来检测差异表达的基因。

结果

我们总共积累了约170万个乳腺组织特异性SAGE标签,并监测了早期乳腺癌发生过程中超过25157个基因的行为。在将正常组织与原位导管癌进行比较时,我们检测到52个转录本普遍失调,而在将原位导管癌与浸润性导管癌进行比较时,检测到149个转录本(P < 0.01)。

结论

我们研究的一个主要新颖之处在于使用了一种统计方法,该方法能够正确考虑SAGE内部和SAGE文库间的变异来源。应用这种改良的t统计β二项式检验最有用的结果是鉴定出在乳腺癌从正常发展到侵袭前和侵袭阶段的每个特定阶段中,跨样本普遍失调的基因和基因家族。在原位阶段检测到的大多数基因表达异常与负责调节细胞死亡和细胞增殖之间适当稳态的特定基因有关。将原位病变与完全浸润性病变(一个更加异质的组)进行比较,清楚地确定编码负责细胞外基质重塑、侵袭和细胞运动功能的各种蛋白质家族的转录本是失调最严重的组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/1192d219d940/bcr899-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/318624c2ba28/bcr899-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/28d6d0f757c4/bcr899-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/dff48b0a0d88/bcr899-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/0ad3cda043dd/bcr899-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/1192d219d940/bcr899-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/318624c2ba28/bcr899-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/28d6d0f757c4/bcr899-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/dff48b0a0d88/bcr899-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/0ad3cda043dd/bcr899-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0397/549167/1192d219d940/bcr899-5.jpg

相似文献

1
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.通过基因表达序列分析确定的人类乳腺癌进展中的转录组变化。
Breast Cancer Res. 2004;6(5):R499-513. doi: 10.1186/bcr899. Epub 2004 Jul 6.
2
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.有证据表明,在乳腺导管癌进展过程中,细胞的分子变化先于形态学改变出现。
Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.
3
Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.调控导管原位癌进展为浸润性乳腺癌的差异表达基因。
Cancer Res. 2012 Sep 1;72(17):4574-86. doi: 10.1158/0008-5472.CAN-12-0636. Epub 2012 Jul 2.
4
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.HIN-1,一种假定的细胞因子,在正常乳腺上皮细胞中高表达,而在癌细胞中不表达。
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. doi: 10.1073/pnas.171138398. Epub 2001 Jul 31.
5
Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.正常组织、DCIS 和浸润性乳腺癌中杂合性丢失与表达谱的比较分析。
Clin Transl Oncol. 2011 Sep;13(9):652-5. doi: 10.1007/s12094-011-0710-1.
6
A SAGE (serial analysis of gene expression) view of breast tumor progression.乳腺癌进展的基因表达系列分析(SAGE)视角。
Cancer Res. 2001 Aug 1;61(15):5697-702.
7
Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.同步导管原位癌和浸润性乳腺癌中具有可比性的癌症相关突变特征。
Cancer Rep (Hoboken). 2020 Jun;3(3):e1248. doi: 10.1002/cnr2.1248. Epub 2020 May 28.
8
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.转录调节因子TBX3促进乳腺癌从非侵袭性向侵袭性进展。
BMC Cancer. 2016 Aug 23;16(1):671. doi: 10.1186/s12885-016-2697-z.
9
Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.原位、浸润性和淋巴管血管侵犯乳腺癌之间差异 microRNA 表达谱分析:一项初步研究。
Clin Exp Metastasis. 2018 Feb;35(1-2):3-13. doi: 10.1007/s10585-017-9868-4. Epub 2017 Dec 6.
10
The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.浸润性乳腺癌的促纤维增生性反应:原发浸润部位的基因表达及其对肿瘤类型比较的意义。
Cancer Res. 2002 Sep 15;62(18):5351-7.

引用本文的文献

1
Multiomics insights on the onset, progression, and metastatic evolution of breast cancer.乳腺癌发病、进展和转移演变的多组学见解
Front Oncol. 2023 Dec 19;13:1292046. doi: 10.3389/fonc.2023.1292046. eCollection 2023.
2
Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.单细胞转录组学揭示了食管鳞状上皮细胞的异质性,并构建了预测患者预后和免疫治疗的模型。
Front Immunol. 2023 Nov 30;14:1322147. doi: 10.3389/fimmu.2023.1322147. eCollection 2023.
3
TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6.

本文引用的文献

1
Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).常染色体显性多囊肾病(ADPKD,MIM 173900,PKD1和PKD2基因,其蛋白质产物分别称为多囊蛋白-1和多囊蛋白-2)
Eur J Hum Genet. 2004 May;12(5):347-54. doi: 10.1038/sj.ejhg.5201162.
2
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.在低级别和高级别人前列腺癌中,聚集素(SGP-2,载脂蛋白J)的表达下调。
Int J Cancer. 2004 Jan 1;108(1):23-30. doi: 10.1002/ijc.11496.
3
Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
TM4SF1 通过与整合素 α6 相互作用促进食管鳞癌细胞转移。
Cell Death Dis. 2022 Jul 14;13(7):609. doi: 10.1038/s41419-022-05067-2.
4
The Role of Extracellular Matrix Proteins in Breast Cancer.细胞外基质蛋白在乳腺癌中的作用
J Clin Med. 2022 Feb 25;11(5):1250. doi: 10.3390/jcm11051250.
5
Transmembrane 4 L Six Family Member 1 Suppresses Hormone Receptor--Positive, HER2-Negative Breast Cancer Cell Proliferation.跨膜4L六家族成员1抑制激素受体阳性、HER2阴性乳腺癌细胞增殖。
Front Pharmacol. 2022 Jan 27;13:770993. doi: 10.3389/fphar.2022.770993. eCollection 2022.
6
Sex-dependent effects of amyloid precursor-like protein 2 in the SOD1-G37R transgenic mouse model of MND.性别依赖性淀粉样前体样蛋白 2 在 SOD1-G37R 转基因 MND 小鼠模型中的作用。
Cell Mol Life Sci. 2021 Oct;78(19-20):6605-6630. doi: 10.1007/s00018-021-03924-5. Epub 2021 Sep 2.
7
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer.淀粉样前体样蛋白2在胰腺癌发生过程中表达增加,并缩短了胰腺癌自发小鼠模型的生存期。
Cancers (Basel). 2021 Mar 26;13(7):1535. doi: 10.3390/cancers13071535.
8
Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.转录组学在个性化癌症医学中的当前成就和应用。
Int J Mol Sci. 2021 Jan 31;22(3):1422. doi: 10.3390/ijms22031422.
9
Chemical carcinogen-induced rat mammary carcinogenesis is a potential model of p21-activated kinase positive female breast cancer.化学致癌物诱导的大鼠乳腺癌发生是一种潜在的 p21 激活激酶阳性女性乳腺癌模型。
Physiol Genomics. 2021 Feb 1;53(2):61-68. doi: 10.1152/physiolgenomics.00112.2020. Epub 2020 Dec 21.
10
Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A (sPLA) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells.靶向 P21 激活激酶-1(PAK-1)和选择性分泌型磷脂酶 A(sPLA)的脂质体降低转移性三阴性乳腺癌细胞活力并诱导细胞凋亡。
Int J Mol Sci. 2020 Dec 10;21(24):9396. doi: 10.3390/ijms21249396.
化疗药物与肿瘤坏死因子相关凋亡诱导配体/Apo-2配体在体内对乳腺癌细胞凋亡及肿瘤消退的协同相互作用。
Cancer Res. 2003 Sep 1;63(17):5390-400.
4
Differential expression in SAGE: accounting for normal between-library variation.SAGE中的差异表达:考虑文库间的正常变异。
Bioinformatics. 2003 Aug 12;19(12):1477-83. doi: 10.1093/bioinformatics/btg173.
5
Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene.细胞质蛋白TRAF4作为p53调控的促凋亡基因的鉴定与表征。
J Biol Chem. 2003 Sep 19;278(38):36435-44. doi: 10.1074/jbc.M303191200. Epub 2003 Jun 4.
6
Transactivation of vimentin by beta-catenin in human breast cancer cells.β-连环蛋白在人乳腺癌细胞中对波形蛋白的反式激活作用。
Cancer Res. 2003 May 15;63(10):2658-64.
7
Nuclear localization of Y-box factor YB1 requires wild-type p53.Y盒因子YB1的核定位需要野生型p53。
Oncogene. 2003 May 8;22(18):2782-94. doi: 10.1038/sj.onc.1206357.
8
Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.通过蛋白质组学方法研究发现,血清和组织中clusterin的缺失均与食管鳞状细胞癌的肿瘤发生相关。
World J Gastroenterol. 2003 Apr;9(4):650-4. doi: 10.3748/wjg.v9.i4.650.
9
Molecular markers in ductal carcinoma in situ of the breast.乳腺导管原位癌中的分子标志物。
Mol Cancer Res. 2003 Mar;1(5):362-75.
10
In silico analysis of the EPS8 gene family: genomic organization, expression profile, and protein structure.EPS8基因家族的计算机分析:基因组组织、表达谱及蛋白质结构
Genomics. 2003 Feb;81(2):234-44. doi: 10.1016/s0888-7543(03)00002-8.